SGLT2‐Is exert renal protection effects in type 2 diabetes by altering renal haemodynamics, reducing intraglomerular pressure, attenuating diabetes‐associated hyperfiltration and tubular hypertrophy, and reducing the tubular toxicity of glucose. The gene discussed is SLC5A2; the disease is diabetes mellitus.